GRAIL, Inc. (NL0)
Munich
Closed
Oct 8, 2026
Day's Range
120.6052 wk Range
36.40Overview - NL0 - GRAIL, Inc.
Key Statistics
Valuation
Enterprise Value
2.03B
P/E (Trailing)
‪-8.51‬
PEG Ratio
‪0.43‬
Price / Sales (TTM)
‪25.57‬
Price / Book
‪1.92‬
EV / EBITDA
‪-6.13‬
Profitability
Gross Margin
‪-28.12%‬
Profit Margin
‪-236.94%‬
Operating Margin
‪-331.99%‬
Return on Assets
‪-12.03%‬
Return on Equity
‪-16.12%‬
Ownership
Shares Outstanding
44.66M
Float
34.30M
Held by Insiders
‪4.99%‬
Held by Institutions
‪86.28%‬
Price stats
Beta
‪3.25‬
50-Day Avg
‪65.10‬
200-Day Avg
‪61.12‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - NL0 - GRAIL, Inc.
Peers - NL0 - GRAIL, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on Munich.
- NL0MunichGRAIL, Inc.4.22BMarket Cap+56.67%52-week change-8.52P/E (Trailing)‪-236.94%‬Profit Margin
- 45EMunichNatera, Inc.52.36BMarket Cap+76.33%52-week change-239.01P/E (Trailing)‪-7.10%‬Profit Margin
- SAB0MunichSonic Healthcare Limited Sponsored ADR5.87BMarket Cap-3.39%52-week change15.53P/E (Trailing)‪5.59%‬Profit Margin
- SH5MunichSotera Health Company4.62BMarket Cap+17.90%52-week change32.40P/E (Trailing)‪13.44%‬Profit Margin
- 1HMMunichAdaptive Biotechnologies Corporation Common Stock4.09BMarket Cap+56.59%52-week change-65.74P/E (Trailing)‪-20.72%‬Profit Margin
- 0MEMunichTwist Bioscience Corporation3.10BMarket Cap+85.89%52-week change-126.15P/E (Trailing)‪50.72%‬Profit Margin
- BMZMunichBML Inc.772.16MMarket Cap-0.97%52-week change18.23P/E (Trailing)‪5.19%‬Profit Margin
Profile Summary - NL0 - GRAIL, Inc.
About
GRAIL, Inc. is a commercial-stage healthcare company focused on multi-cancer early detection testing and services. Its core offering is Galleri, a blood-based screening test designed to detect multiple cancer types before symptoms appear, supporting earlier clinical evaluation and diagnosis. The company uses…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
